T. Rowe Price Biotech ETF (TDNA)

Assets	$10.10M
Expense Ratio	0.55%
PE Ratio	n/a
Forward PE	n/a
Shares Out	425,000
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,704
Open	24.81
Previous Close	24.50
Day's Range	24.81 - 24.99
52-Week Low	22.72
52-Week High	25.68
Beta	n/a
Holdings	n/a
Inception Date	Sep 16, 2026

About TDNA

Fund Home Page

The T. Rowe Price Biotech ETF (TDNA) is an exchange-traded fund. The fund's investment portfolio concentrates primarily on health care equity. TDNA provides targeted exposure to global biotechnology companies through an actively managed ETF TDNA was launched on Sep 16, 2026 and is issued by T. Rowe Price.

• Asset Class: Equity
• Category: Health
• Stock Exchange: Nasdaq
• Ticker Symbol: TDNA
• ETF Provider: T. Rowe Price

Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 29, 2026

Data Sources Report a data error